Among the changes, oncogenes such as ADAM19, EPHA3, and KLF4 showed increased expression, but tumor suppressors like CDKN2A and BRCA2 demonstrated decreased expression by inhibition of METTL3- or METTL14. This evidence concerns the gene METTL14 and neoplasm.